Literature DB >> 1285354

Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in nonneoplastic hepatobiliary diseases.

Y Nakanuma1, N Kono.   

Abstract

Biliary epithelial cells express characteristically cytokeratin in their cytoplasm in normal and diseased livers. The present study disclosed that vimentin was frequently expressed in the cytoplasm of proliferating and damaged bile ductules and interlobular bile ducts, while their normal counterparts were negative for vimentin. Although this expression itself seemed nonspecific to any of the hepatobiliary diseases examined, bile ductules and interlobular bile ducts were frequently positive in chronic cholestatic and necroinflammatory liver diseases. In biliary epithelial cells, vimentin was localized around the nucleus or in the subnuclear regions, when present. Immunoelectron microscopically, reaction products for vimentin and for cytokeratin were found on bundles of intermediate filaments in the cytoplasm of biliary epithelial cells. The former was found mostly in the paranuclear and subnuclear regions, while the latter detected around the desmosomes, in addition to the paranuclear cytoplasm. Vimentin and cytokeratin were also seen together under immunoelectron microscopy on the same intermediate filaments. It seems likely that aberrant expression of vimentin in bile ductules and interlobular bile ducts and heterogeneous antigenic expression of intermediate filaments in the same biliary epithelial cells may be related to proliferation of, reorganization of, or damage to the ductular and ductal biliary cells in a variety of hepatobiliary diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285354

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

Review 1.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

2.  Efficient generation of biliary epithelial cells from rabbit intrahepatic bile duct by Y-27632 and Matrigel.

Authors:  Lifang Jin; Shaohui Ji; Aijing Sun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-14       Impact factor: 2.416

3.  Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis.

Authors:  Li-Jen Su; Shih-Lan Hsu; Jyh-Shyue Yang; Huei-Hun Tseng; Shiu-Feng Huang; Chi-Ying F Huang
Journal:  Gene Expr       Date:  2006

Review 4.  Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.

Authors:  Kenichi Harada
Journal:  Pediatr Surg Int       Date:  2017-10-16       Impact factor: 1.827

5.  Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.

Authors:  Anthony J Demetris; Susan Specht; Isao Nozaki; John G Lunz; Donna Beer Stolz; Noriko Murase; Tong Wu
Journal:  J Hepatol       Date:  2007-12-17       Impact factor: 25.083

6.  Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.

Authors:  Yasunori Sato; Kenichi Harada; Satoru Ozaki; Shinichi Furubo; Kazuo Kizawa; Takahiro Sanzen; Mitsue Yasoshima; Hiroko Ikeda; Motoko Sasaki; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

Review 7.  Biliary innate immunity: function and modulation.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Mediators Inflamm       Date:  2010-07-27       Impact factor: 4.711

8.  Cholangiopathy with respect to biliary innate immunity.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-11

9.  Cystic cholangioma in the thoracic cavity of a rat.

Authors:  Yoshiko Michimae; Kazuo Okimoto; Kaoru Toyosawa; Izumi Matsumoto; Mami Kouchi; Tomoaki Tochitani; Takatoshi Koujitani; Hitoshi Funabashi; Takaki Seki
Journal:  J Toxicol Pathol       Date:  2012-03       Impact factor: 1.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.